Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Yatoh

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Biochemical and Biophysical Research Communications|December 17, 2009
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalphaHirosuke Danno, Kiyo-aki Ishii, Yoshimi Nakagawa, et al.
Diabetes|May 7, 2008
Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic isletsToyonori Kato, Hitoshi Shimano, Takashi Yamamoto, et al.
Molecular Endocrinology (Baltimore, Md.)|May 6, 2003
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signalingTomohiro Ide, Hitoshi Shimano, Tomohiro Yoshikawa, et al.
The Journal of Biological Chemistry|September 14, 2011
Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in miceShin Kumadaki, Tadayoshi Karasawa, Takashi Matsuzaka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient miceRyo Saito, Takashi Matsuzaka, Tadayoshi Karasawa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 7, 2011
Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient miceTadayoshi Karasawa, Akimitsu Takahashi, Ryo Saito, et al.
Endocrinology|July 26, 2013
TFE3 controls lipid metabolism in adipose tissue of male mice by suppressing lipolysis and thermogenesisYuri Fujimoto, Yoshimi Nakagawa, Aoi Satoh, et al.
Plos One|June 23, 2016
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in MiceNoriko Suzuki-Kemuriyama, Takashi Matsuzaka, Motoko Kuba, et al.
Molecular Endocrinology (Baltimore, Md.)|May 6, 2003
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signalingTomohiro Yoshikawa, Tomohiro Ide, Hitoshi Shimano, et al.
Diabetes|May 3, 2017
Elovl6 Deficiency Improves Glycemic Control in Diabetic <i>db</i>/<i>db</i> Mice by Expanding β-Cell Mass and Increasing Insulin Secretory CapacityHui Zhao, Takashi Matsuzaka, Yuta Nakano, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|December 17, 2009
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalphaHirosuke Danno, Kiyo-aki Ishii, Yoshimi Nakagawa, et al.
Diabetes|May 7, 2008
Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic isletsToyonori Kato, Hitoshi Shimano, Takashi Yamamoto, et al.
Molecular Endocrinology (Baltimore, Md.)|May 6, 2003
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signalingTomohiro Ide, Hitoshi Shimano, Tomohiro Yoshikawa, et al.
The Journal of Biological Chemistry|September 14, 2011
Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in miceShin Kumadaki, Tadayoshi Karasawa, Takashi Matsuzaka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient miceRyo Saito, Takashi Matsuzaka, Tadayoshi Karasawa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 7, 2011
Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient miceTadayoshi Karasawa, Akimitsu Takahashi, Ryo Saito, et al.
Endocrinology|July 26, 2013
TFE3 controls lipid metabolism in adipose tissue of male mice by suppressing lipolysis and thermogenesisYuri Fujimoto, Yoshimi Nakagawa, Aoi Satoh, et al.
Plos One|June 23, 2016
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in MiceNoriko Suzuki-Kemuriyama, Takashi Matsuzaka, Motoko Kuba, et al.
Molecular Endocrinology (Baltimore, Md.)|May 6, 2003
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signalingTomohiro Yoshikawa, Tomohiro Ide, Hitoshi Shimano, et al.
Diabetes|May 3, 2017
Elovl6 Deficiency Improves Glycemic Control in Diabetic <i>db</i>/<i>db</i> Mice by Expanding β-Cell Mass and Increasing Insulin Secretory CapacityHui Zhao, Takashi Matsuzaka, Yuta Nakano, et al.
Pageof 6